prof.dr. M.J. IJzerman (Maarten)

Scientific visitors

About Me

Maarten J. IJzerman is professor and head of Cancer Health Services Research in the University of Melbourne and Peter MacCallum Cancer Centre and a part-time professor in the University of Twente's TechMed Centre. His international work is focussed on the health economics and health services implications of personalised medicine, including drug treatment sequencing and the use of complex genomic sequencing. He develops and applies new methods for value assessment of medical technologies, in particular molecular diagnostics for precision oncology. He is a pioneer in the field of early Health Technology Assessment, supporting the clinical translation of medical innovation by modelling their health and economic impact in an early stage of development. 

Before moving to Melbourne in 2018, he was the founding chair of the Department of Health Technology and Services Research (2007-2015), director of education for Health Sciences program (2007-2011), acting director of the MIRA institute for Biomedical Engineering and Technical Medicine (2013-2014) and vice-dean for Health & Biomedical Technology in the Faculty of Science and Technology (2015-2017). Before then, he worked as a visiting scholar in different academic centres in the USA and Canada and was the scientific director of Roessingh Research and Development (2000-2007). 

Maarten has supervised many MSc and PhD students in several UT degree programs (TM, HS, BME and IEM) and is a mentor to early-to-mid career academics globally. 


Social Sciences
Health Economics
Medicine & Life Sciences
Cost-Benefit Analysis
Costs And Cost Analysis
Decision Support Techniques
Delivery Of Health Care

Ancillary Activities

  • Erasmus University Rotterdam
    Academic, fulltime position
  • Laboratorium Microbiologie
    Raad van Toezicht


Rizvi, F., Wilding, H. E., Rankin, N. M., Le Gautier, R., Gurren, L., Sundararajan, V., Bellingham, K., Chua, J., Crawford, G. B., Nowak, A. K., Le, B., Mitchell, G., McLachlan, S. A., Sousa, T. V., Hudson, R. , IJzerman, M., Collins, A., & Philip, J. (2023). An evidence-base for the implementation of hospital-based palliative care programs in routine cancer practice: A systematic review. Palliative Medicine. https://doi.org/10.1177/02692163231186177
van Til, J. A. , Kip, M. M. A., Schatorjé, E. J. H., Currie, G., Twilt, M., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N., Yeung, R. S. M. , Groothuis-Oudshoorn, C. G. M. K., Warta, S., Marshall, D. A. , IJzerman, M. J., & UCAN CAN-DU, UCAN CURE consortia (2023). Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists? Pediatric rheumatology online journal, 21(1), 69. [69]. https://doi.org/10.1186/s12969-023-00845-4
Drosdowsky, A., Lamb, K. E., Bergin, R. J., Boyd, L., Milley, K. , IJzerman, M. J., & Emery, J. D. (2023). A systematic review of methodological considerations in time to diagnosis and treatment in colorectal cancer research. Cancer epidemiology, 83, [102323]. https://doi.org/10.1016/j.canep.2023.102323
To, Y. H., Gibbs, P., Tie, J. , IJzerman, M., & Degeling, K. (2023). Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost effectiveness and resource allocation, 21(1), [11]. https://doi.org/10.1186/s12962-023-00422-2
O’Haire, S., Franchini, F., Kang, Y. J., Steinberg, J., Canfell, K., Desai, J., Fox, S. , & IJzerman, M. (2023). Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours. Scientific reports, 13(1), [4116]. https://doi.org/10.1038/s41598-023-31055-3

UT Research Information System

Google Scholar Link


I am committed to teaching in graduate programs in the University of Twente and Melbourne as well as international short-courses for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Affiliated Study Programmes


Courses Academic Year  2023/2024

Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.

Courses Academic Year  2022/2023

News on utwente.nl

  • https://www.utoday.nl/covid-19-research-at-ut/68467/delays-in-cancer-treatments-due-to-corona-crisis
  • https://www.utwente.nl/en/news/2018/3/39094/maarten-ijzerman-to-lead-world-class-cancer-research-program-in-melbourne



Contact Details

Visiting Address

University of Twente
Drienerlolaan 5
7522 NB Enschede
The Netherlands

Navigate to location

Mailing Address

University of Twente
P.O. Box 217
7500 AE Enschede
The Netherlands

Social Media